Results

Total Results: 103 records

Showing results for "consideration".

1. Recommendation #8: Naloxone Consideration | CDS Connect
   cds.ahrq.gov/cdsconnect/artifact/recommendation-8-naloxone-consideration
   September 27, 2018 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates

2. Clostridium Difficile (C.Diff) Infection Treatment Pathway Updated March 2019 (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/686/Clostridium%20difficile%20(C.diff)%20Infection%20Treatment%20Pathway_updated%20March%202019.pdf
   June 20, 2019 - fulminant CDI NO, First CDI Episode YES, Recurrent CDI Episode Consult infectious disease (ID) for consideration

3. Implementation Guide: Prediabetes and Type 2 Diabetes: Part One, Screening (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/1061/2024_CDS_Connect_IG_Diabetes_Part_One_Screening_0.pdf
   January 01, 2024 - As part of the Patient Population Under Consideration section of the full recommendation statement, … Inclusions (from the Patient Population Under Consideration section) “Race = African American … Inclusions (from the Patient Population Under Consideration section) “Ethnicity = Hispanic … Although the racial/ethnic groups identified in the Patient Population Under Consideration section of … Add explanation “No symptoms of diabetes” The Patient Population Under Consideration section of the

4. CDS Connect Work Group Meeting Summary 11-19-2020 (pdf file)
   cds.ahrq.gov/sites/default/files/workgroups/1236/CDS_Connect_WG_Nov2020_Summary.pdf
   November 19, 2020 - property surrounding the proposed workflow of CDS Connect use case—specifically if there had been consideration … components to be used on their own, and that publishing to Node Package Manager (NPM) is a future consideration

5. Implementation Guide: Prediabetes and Type 2 Diabetes: Part Two, Counseling (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/1066/2024_CDS_Connect_IG_Diabetes_Part_Two_Counseling_1.pdf
   January 01, 2024 - Depending on the availability and comprehensiveness of patient data sources, consideration of other … As part of the Patient Population Under Consideration section of the full recommendation statement, … Inclusions (from the Patient Population Under Consideration section) “Race = African American … Inclusions (from the Patient Population Under Consideration section) “Race = American Indian … Inclusions (from the Patient Population Under Consideration section) “Ethnicity = Hispanic or

6. Jul-2017-Cholesterol-Wg-Notes (doc file)
   cds.ahrq.gov/sites/default/files/workgroups/246/jul-2017-cholesterol-wg-notes.docx
   January 01, 2017 - Given the testing timeline, the implementation team decided to include this consideration in the recommendation … Clinical Domains CAMH requested the WG’s feedback and experiences with numerous clinical domains under consideration … CDS warnings about high risk meds is a consideration.

7. Implementation Guide: Prediabetes and Type 2 Diabetes: Part One, Screening (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/1061/508_2022_CDS_Connect_IG_T2DM_Part_One_Screening_final.pdf
   January 01, 2022 - Depending on the availability and comprehensiveness of patient data sources, consideration of other … Inclusions (from the Patient Population Under Consideration section) “polycystic ovary syndrome … Inclusions (from the Patient Population Under Consideration section) “race = African American … Inclusions (from the Patient Population Under Consideration section) “ethnicity = Hispanic … Although the racial/ethnic groups identified in the Patient Population Under Consideration section of

8. Implementation Guide: Prediabetes and Type 2 Diabetes: Part One, Screening (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/1061/Implementation_Guide_Prediabetes_and_Type_2_Diabetes_Part_One_Screening.pdf
   September 01, 2022 - Depending on the availability and comprehensiveness of patient data sources, consideration of other … Inclusions (from the Patient Population Under Consideration section) “polycystic ovary syndrome … Inclusions (from the Patient Population Under Consideration section) “race = African American … Inclusions (from the Patient Population Under Consideration section) “ethnicity = Hispanic … Although the racial/ethnic groups identified in the Patient Population Under Consideration section of

9. Implementation Guide: Prediabetes and Type 2 Diabetes: Part One, Screening (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/1061/2023_CDS_Connect_IG_T2DM_Part_One_Screening_1.pdf
   January 01, 2023 - Depending on the availability and comprehensiveness of patient data sources, consideration of other … Inclusions (from the Patient Population Under Consideration section) “polycystic ovary syndrome … Inclusions (from the Patient Population Under Consideration section) “race = African American … Inclusions (from the Patient Population Under Consideration section) “ethnicity = Hispanic … Although the racial/ethnic groups identified in the Patient Population Under Consideration section of

10. May 2020 CDS Connect Work Group Call (pdf file)
    cds.ahrq.gov/sites/default/files/workgroups/1176/CDS%20Connect%20Work%20Group%20May%202020%20Meeting%20Slides.pdf
    May 01, 2020 - reviewed’ status 19 DISCUSSION: WHAT ARE OTHER ASPECTS OF CDS ARTIFACT MAINTENANCE FOR FUTURE CONSIDERATION … Slide 4 of 4) Next Steps Discussion:�What Are Other aspects of CDS Artifact maintenance for future consideration

11. Implementation Guide: Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Part One, Screening (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1061/Implementation%20Guide_Abnormal%20Blood%20Glucose%20and%20Type%202%20DM_Part%20One,%20Screening_Final.pdf
    September 01, 2019 - Depending on the availability and comprehensiveness of patient data sources, consideration of other … Within the Patient Population Under Consideration section of the USPSTF full recommendation statement … Within the Patient Population Under Consideration, the recommendation indicates that persons with specific … Inclusions (from the Patient Population Under Consideration section) “ethnicity = Hispanic … Although the racial/ethnic groups identified in the Patient Population Under Consideration section of

12. Implementation Guide: Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Part Two, Counseling (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1066/Implementation%20Guide_Abnormal%20Blood%20Glucose%20and%20Type%202%20DM_Part%20Two%20Counseling_Final.pdf
    September 01, 2019 - Depending on the availability and comprehensiveness of patient data sources, consideration of other … Within the Patient Population Under Consideration section of the USPSTF full recommendation statement … Within the Patient Population Under Consideration, the recommendation indicates that persons with specific … Inclusions (from the Patient Population Under Consideration section) “Ethnicity = Hispanic … Although the racial/ethnic groups identified in the Patient Population Under Consideration section of

13. Implementation Guide: Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Part Two, Counseling (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1066/Implementation%20Guide%20Abnormal%20Blood%20Glucose%20and%20Type%202%20DM%20Counseling.pdf
    September 01, 2021 - Depending on the availability and comprehensiveness of patient data sources, consideration of other … Within the Patient Population Under Consideration, the recommendation indicates that persons with specific … Inclusions (from the Patient Population Under Consideration section) “Family history of diabetes … Inclusions (from the Patient Population Under Consideration section) “Polycystic ovary syndrome … Although the racial/ethnic groups identified in the Patient Population Under Consideration section of

14. Implementation Guide: Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Part One, Screening (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1061/IG%20Abnormal%20Blood%20Glucose%20Type%202%20DM%20Screening.pdf
    September 01, 2021 - Depending on the availability and comprehensiveness of patient data sources, consideration of other … Within the Patient Population Under Consideration section of the USPSTF full recommendation statement … Within the Patient Population Under Consideration, the recommendation indicates that persons with specific … Inclusions (from the Patient Population Under Consideration section) “Family history of diabetes … Although the racial/ethnic groups identified in the Patient Population Under Consideration section of

15. Implementation Guide: Prediabetes and Type 2 Diabetes: Part Two, Counseling (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1066/2023_CDS_Connect_IG_T2DM_Part_Two_Counseling_0.pdf
    January 01, 2023 - Depending on the availability and comprehensiveness of patient data sources, consideration of other … As part of the Patient Population Under Consideration section of the full recommendation statement, … Inclusions (from the Patient Population Under Consideration section) “Race = African American … Inclusions (from the Patient Population Under Consideration section) “Race = American Indian … Inclusions (from the Patient Population Under Consideration section) “Ethnicity = Hispanic or

16. Feb-2017-Cholesterol-Wg-Notes (doc file)
    cds.ahrq.gov/sites/default/files/workgroups/221/feb-2017-cholesterol-wg-notes.docx
    January 01, 2017 - Discuss Remaining Repository Questions CAMH provided a brief overview of the metadata under current consideration

17. Dec-2016-Cholesterol-Wg-Notes (doc file)
    cds.ahrq.gov/sites/default/files/workgroups/211/dec-2016-cholesterol-wg-notes.docx
    January 01, 2016 - validate identified artifacts for potential CDS build out, and identify additional clinical resources for consideration … Sources TBD · Rules generated from CPGs · ASCVD – Yes/No · Determine 4 high risk groups for LLT consideration

18. Title of document or resource (doc file)
    cds.ahrq.gov/sites/default/files/workgroups/226/mar-2017-cholesterol-wg-notes.docx
    January 01, 2017 - other than cirrhosis, e.g. fatty liver disease, shouldn’t be automatically excluded from statin therapy consideration

19. CDS Connect Work Group Meeting Summary 1-16-2020 (pdf file)
    cds.ahrq.gov/sites/default/files/workgroups/1116/CDS%20Connect%20Work%20Group%20Meeting%20Summary%202020%20January-508.pdf
    January 16, 2020 - Potential alignment options presented for consideration and discussion included: • Aligning the CDS

20. Jun-2017-Cholesterol-Wg-Notes (doc file)
    cds.ahrq.gov/sites/default/files/workgroups/241/jun-2017-cholesterol-wg-notes.docx
    January 01, 2017 - Steps and Closing CAMH will provide an update on the pilot and discuss clinical domain areas under consideration